Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001879231-25-000002

EVP, R&D and CMO gave up 7,878 shares (to pay taxes)

  • EVP, R&D and CMO acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Buck Kristen K · EVP, R&D and CMO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-09 Grant or award : show line 1 in the form +25,000 87,672 D
2025-01-09 Shares withheld for taxes : show line 2 in the form −2,651 $3.80 $10,074 85,021 D
2025-01-09 Shares withheld for taxes : show line 3 in the form −2,863 $3.80 $10,879 82,158 D
2025-01-09 Shares withheld for taxes : show line 4 in the form −1,908 $3.80 $7,250 80,250 D
2025-01-10 Shares withheld for taxes : show line 5 in the form −456 $3.73 $1,701 79,794 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-09 Grant or award : show line 6 in the form Stock Option (Right to Buy) +13,000 13,000 D
Loading xslF345X05/wk-form4_1736802577.xml…